4 Mesothelioma Information

Mesothelioma Cancer Advocate, Doctor, and Volunteers Recognized

2009-06-26T00:39:00.000-05:00

Mesothelioma Doctor, Advocate and Volunteers Recognized by the Mesothelioma Applied Research Foundation

The Mesothelioma Applied Research Foundation will present three awards at the International Symposium on Malignant Mesothelioma on Friday, June 26th in Washington, DC. This year's award recipients include Dr. Robert Taub, Terry Lynch, and Craig & Shelly Kozicki. Galvanizing our community's tremendous diversity, talent, strength and knowledge is the key to developing more effective mesothelioma treatments and, one day, the cure. I am proud to be a part of this vibrant and dedicated community and I applaud this year's award recipients

Santa Barbara, CA (PRWEB) June 22, 2009 -- To recognize the extensive studies, long hours and personal investment of those involved in eradicating mesothelioma, the Mesothelioma Applied Research Foundation will present three awards at the Gala Celebration of Hope on Friday June 26th, day two of the International Symposium on Malignant Mesothelioma, to be held Thursday, June 25th through Saturday, June 27th at the Omni Shoreham, in Washington, DC.

"Galvanizing our community's tremendous diversity, talent, strength and knowledge is the key to developing more effective mesothelioma treatments and, one day, the cure. I am proud to be a part of this vibrant and dedicated community and I applaud this year's award recipients," says Dr. Nicholas Vogelzang, Chairman of the Meso Foundation's Board of Directors.

The Pioneer Award emphasizes the contributions of Dr. Robert Taub, MD PhD, whose treatment protocols and vision have shown remarkable results and have been the basis of hope for many mesothelioma patients; The Bruce Vento Hope Builder Award, named for the late Minnesota Congressman who died from mesothelioma in 2000, acknowledges the support and initiatives of Terry Lynch, International Vice President, Political & Legislative Director and Health Hazard Administrator of the International Association of Heat and Frost Insulators and Allied Workers; and The Volunteer of the Year Award honors Craig and Shelly Kozicki for being an inspiration to the mesothelioma community through their continued dedication in raising research funds and providing support and hope to others faced with mesothelioma. Craig, who had been diagnosed with mesothelioma in 1998, died in May of this year.

The Symposium, organized annually by the Mesothelioma Applied Research Foundation, will highlight the latest advances in research and treatment for patients and caregivers, offer psychosocial support to them as well as those who have lost someone to the disease, and provide all who are intent on eradicating the vicious and terminal effects of this tragic cancer with significant advocacy and volunteer opportunities. The three-day conference is dedicated to mesothelioma science, advocacy, and community.

Those wishing to attend can register for the symposium and get additional information on the Meso Foundation's website.

The Mesothelioma Applied Research Foundation is the national non-profit dedicated to finding a cure for mesothelioma by funding mesothelioma research, providing mesothelioma patients support services and participating in federal mesothelioma advocacy. Visit www.curemeso.org for more information.

CONTACT INFORMATION
Maja Belamaric
Mesothelioma Applied Research Foundation (Meso Foundation)
(805) 456-7272

Second Mesothelioma Search Engine Launches

2009-06-10T11:11:00.000-05:00

LegalView Launches Mesothelioma Search Engine

Denver, CO, June 10, 2009 --(PR.com)-- LegalView, the most expansive legal resource available on the Web, has announced the development of an exciting new mesothelioma search engine. This new utility allows users to search through an extensive database of articles pertaining to mesothelioma, sites containing information on asbestos exposure, and the development of mesothelioma cancer. This exciting development promises to connect users with the resources they need to find useful and important mesothelioma information for those seeking a one-stop resource for pertinent, relevant, and concise information on mesothelioma cancer and asbestos exposure. Additionally the search engine can provide users with assistance finding a mesothelioma lawyer.

LegalView has long been at the forefront of connecting users with the help they need. For example, LegalView's mesothelioma information portal continues to provide comprehensive coverage of all elements relating to mesothelioma and asbestos exposure, as well as offering a simple and direct case evaluation form for anyone who might need more information regarding a potential mesothelioma lawsuit This service will prove to be an exceptional mechanism for searching and identifying useful articles and other online information regarding mesothelioma.

Mesothelioma cancer is often considered a fatal condition for which no known treatment can currently completely cure the effects of the cancer, which is why it is imperative that a patient recently diagnosed with mesothelioma cancer locate an experienced mesothelioma lawyer who can provide a free legal consultation as to the development of a possible mesothelioma law suit. Developing litigation of this nature may result in monetary funds being dispersed to a victim, who can then use such compensation to pay for costly medical treatments and increase quality of life during their cancer.

In addition to offering exhaustive resources pertaining to mesothelioma, LegalView has also recently announced the relaunch of its construction accident information portal, adding to the extensive knowledge base of the LegalView.info family of information portals. This announcement promises to be extremely valuable for individuals and families who have either been affected by accidents on construction sites or who have personally sustained injuries from working on a construction site. The construction accident information portal provides users with informative articles relating to construction accidents as well as LegalView's construction accident attorney referral system. According to the latest data released by the Federal Bureau of Labor Statistics, construction site accidents account for the highest number of fatal occupational injuries, that is, deadly accidents while on a job site. In 2007, 1,204 fatalities were reported in the construction sector.

LegalView consistently offers individuals who have been the victims of injury or harmful exposure the opportunity to connect with an experienced injury lawyer for free using a simple contact form. The exemplary record of the attorneys and the professional service they provide sets them as the premier resource for anyone seeking information about mesothelioma treatment, construction accidents, or a host of other legal issues.

Contact Information
LegalView
Katie Kelley
720-226-6613
press-releases@legalview.com
http://mesothelioma.legalview.com

There is also a Mesothelioma Search Engine that was created by Nielsen Technical Services back in February of 2006 that spiders and indexes medical and legal sites on the topic of mesothelioma cancer and asbestos. -Ed.

Asbestos Bondage Studied

2009-06-08T14:14:00.000-05:00

Asbestos Fiber Links With The Human Cells

2009-06-07 (WiredPRNews.com - Mesothelioma Asbestos, Press Releases)Dallas, TX: The Ohio University team of scientists are trying to establish individual bondage of the asbestos fiber and the human cell. There are two major forms , under their observation. Both of these forms are linked with the exposure of asbestos. Those people, who work at the asbestos job sites are the main targets. The onset takes place due to the inhalation or the swallowing of the tiny, microscopic fibers. These two forms of diseases are:

Asbestosis: It's a chronic respiratory disease. The attack is on the respiratory track, and it proves fatal. No cure has been discovered so far.

Mesothelioma: This infection can be of the lungs, chest or of the heart. There is no cure for this disease, too, and the prognosis is of six to twelve months, once the symptoms appear.

Asbestos occurs in six different forms, in nature, all these forms have proved deadly. Due to its qualities of durability and high resistance, it was widely used in a number of industries, till the first half of the last century. By the year 1940, it was totally banned in about forty countries of Europe and the United States, but asbestos is still present inn the manufactured stuff and is considered dangerous to human life. The breaking of the asbestos-related goods and the demolition of old buildings and structures, spread the dust and the fiber into the open atmosphere.

The team of scholars is using the 'Atomic Force Microscopy' to study, as to how a single fiber, during the exposure, after inhaling, clings itself with the cell surface of the lining of the organs.

One of the research candidates, has described this study as a type of 'braille work between the two ends of this bondage and says that the scientists will feel and observe, how the asbestos links with the human cells.

The U.S, Department of labor estimates about 1.3 million people will be the target of this disease in the coming years. This is the number of the labor exposed to asbestos, from 1960s up to '80s.

Drug Toxicity Assay Kits Increase Drug Development Efficiency

2009-06-01T00:21:00.000-05:00

Bioo Scientific's Toxicity Assay Kits Increase the Efficiency of Drug Development

Bioo Scientific announced the launch of the MaxDiscoveryT Toxicity Assay Kits for the monitoring of toxic effects in in vivo preclinical studies.

Austin, TX, May 31, 2009 -- Since toxicity is one of the leading causes of drug failures, measuring preclinical toxicity is a critical drug development function. Accurate in vivo toxicity assays are essential to lowering attrition and increasing efficiency in drug development.

Bioo Scientific announced today the launch of their MaxDiscoveryT Toxicity Assay Kits. These kits monitor in vivo toxicity by measuring liver and heart function in serum samples. They provide simple, convenient, colorimetric determination of well-characterized functional markers of for liver and heart. They are ideal tools to monitor toxic effects caused by administration of siRNA, DNA plasmids, transfection agents or other therapeutic treatments during preclinical studies. The assays can be used in a range of mammals, including mice and rats, providing a powerful tool to assess and reduce the toxicity of drugs formulations and to improve drug delivery methods.

According to Dr Joe Krebs, Director of Protein Chemistry and Engineering at Bioo Scientific, "MaxDiscoveryT Toxicity kits are designed to provide researchers with rapid, cost-effective tools required to address the escalating challenges of drug development in today's competitive landscape."

Assays are available for alanine transaminase, aspartate transminase, alkaline phosphatase, lactate dehydrogenase, cholesterol, and creatine kinase.

About Bioo Scientific
Bioo Scientific Corporation is a global biotechnology tools company, headquartered in Austin, Texas. Bioo Scientific provides innovative products and services to academic researchers, pharmaceutical and biotechnology companies, molecular diagnostics laboratories, and customers who perform food and feed safety analysis.

Contact Information
Bioo Scientific
Dawn Obermoeller
512-301-4094
dawn@redbridgemarketing.com
www.biooscientific.com

Truck Drivers At Greater Risk For Lung Cancer

2009-04-06T10:09:00.001-05:00

Diesel Users Suffer More Lung Cancer; a Simple Solution is to Hand from ChemEcol and VEPower

Those who work with and at close proximity to diesel engines, especially lorry drivers, are at a higher risk of cancer according to a recent US study. This is on top of the elevated risk of "heart disease and stroke, possibly resulting from enhanced coagulation and arterial thrombosis" such exposure gives. The good news is that a British company has developed a fuel technology that is seen to significantly reduce ultra fine particulate emissions by as much as 45%.

Welwyn Garden City, United Kingdom, March 28, 2009 -- Truckers endure such grave risks as lung cancers, heart disease and stroke all the time they run their engines. But it's not just the lorry drivers who are at risk. The American study also saw that those working with the and near trucks (fork truck drivers, warehousemen, mechanics, and even office workers) are at elevated risk from these killers. Why?

Diesel exhaust carries particulate matter; this is what colours it smoky black. Particulates are both created by and carriers of toxic substances called polycyclic aromatic hydrocarbons (PAHs). Many of these are known to be particularly carcinogenic, mutagenic. Some of these particles are small enough (100nm or less) to be classified as nanoparticles. These have been found to become distributed around the body via the blood supply once inhaled with notable deposits being found in the liver and heart. If ingested (when particles have settled on food or in drink) they will also pass into the gastro-intestinal tract (4).

It's not just haulage workers and their colleagues who are at risk. Black carbon (again, part of the exhaust) exposure in city children has been shown to reduce development in terms of intelligence (5). The particulate matter we have been looking at is known also to exacerbate respiratory complaints, allergies such as asthma and may agitate some skin complaints also. Some studies have found that certain particulate constituents can be carcinogenic on the skin as well as when inhaled (6).

ChemEcol (UK) Ltd. makes the combustion enhancer Additone. The technology has been developed as a response to the grave threats posed by vehicle exhaust pollution. ChemEcol's products are not based on metallic catalysts, nano-technology or otherwise, as such would counteract the goal of reducing particulate pollutant emissions (the metallic particles would be exhausted along with the other emissions). In fact this technology is based on pure hydrocarbon formulations, maintaining the physical properties of the diesel.

ChemEcol's patented technology modifies the processes of fuel combustion inside the engine, reducing the particulates produced at the most fundamental level. This has a beneficial side-effect of reducing fuel consumption as the PAHs otherwise produced can be considered to be wasted fuel. This change then reduces CO2 emissions and costs by an average of 3%.

VEPower Ltd markets ChemEcol's product. They can be reached at ChemEcol on +44 (0) 1707 330400, at www.chemecol.net and neil@chemecol.net.

Contact Information
ChemEcol Ltd
Nel Faulkner
+44 (0) 20 3286 8771
neil@chemecol.net
www.chemecol.net

Record Year For Asbestos Claims

2009-02-17T22:27:00.000-06:00

Field Fisher Waterhouse reports record year for Asbestos Claims Group

WEBWIRE - Monday, February 16, 2009 - In 2008, the Asbestos Claims Group at law firm Field Fisher Waterhouse LLP recovered record levels of compensation for victims of asbestos-related diseases in 124 successful cases, resulting in over £16 million. Over the years, the lawyers in the firm's Asbestos Claims Group have recovered a total of £132 million in 2025 successful claims.

Some of the significant asbestos claims cases over the past year have included:

- Negotiating an award of £703,000 for the widow and family of a 52 year old partner in an engineering firm who died from mesothelioma following exposure to asbestos at work. This is amongst only a handful of awards exceeding £500,000 across England and Wales.*

- Winning £100,000 damages (plus legal costs) for a retired teacher who developed mesothelioma by using drawing pins to pin children's work to the walls of her prefab classroom, which contained asbestos.**

- In a landmark case the firm recovered £12,500 for the value of hospice care as part of a £170,000 settlement for a man who worked with asbestos in 1963 and contracted mesothelioma in 2005. The funding of hospice care is almost exclusively by charitable donation and this is thought to be the first time a firm of solicitors has recovered the cost of care in this way.***

- Field Fisher Waterhouse acted for the family of a 75 year old man who died due to mesothelioma, and who used to take care of his grandchildren after school in term times. The defendants initially denied that this was compensatable, since there was no reported precedent for it, however the firm recovered £109,352 at a High Court hearing including £27,960 for the grandchildren's care.****

The FFW team of asbestos lawyers has also been actively lobbying the House of Commons, requesting that the Government overturn the House of Lords ruling that pleural plaques - a scarring of the lining of the lungs as a result of exposure to asbestos - is not a compensatable disease. The team also responded to the Ministry of Justice's consultation on the Law Lords' pleural plaques ruling.

Asbestos-related diseases affect thousands of people in the UK each year. Factory workers and labourers are amongst those who are commonly affected, but Field Fisher Waterhouse has also acted on behalf of professionals such as doctors, nurses and teachers who have been exposed to asbestos through their work. Field Fisher Waterhouse LLP is a leader in the field of Asbestos Claims.

Rodney Nelson-Jones, head of the Asbestos Claims group at Field Fisher Waterhouse, said: "I am delighted that in 2008 we were able to win over £16 million in compensation for the victims of these terrible diseases. It is crucial that sufferers and their families receive the compensation they deserve"

About Field Fisher Waterhouse
Field Fisher Waterhouse LLP is a full-service European law firm with offices in Brussels, Hamburg and London. With 119 partners, over 200 other lawyers and nearly 300 support staff, FFW assist a wide range of international clients, advising across a full range of legal issues. The main areas of practice are corporate and commercial, IP and technology, banking and finance, regulatory and real estate. Field Fisher Waterhouse LLP also have particular expertise in competition & EU law, dispute resolution, employment, asbestos claims and mesothelioma claims, personal injury, spinal injury cases and medical negligence, public sector and tax.

Contact Information
    Louise Eckersley
    PR Manager
    Field Fisher Waterhouse LLP
    020 7861 4120
    enquiries@pr-sending.co.uk

For further press information please contact:
Louise Eckersley
PR Manager
Field Fisher Waterhouse LLP
35 Vine Street
London EC3N 2AA United Kingdom
020 7861 4120
www.personalinjury.ffw.com

Related Links
    Asbestos Claims
    Personal Injury
    Medical Negligence

Years of Potential Life Lost From Asbestos Exposure

2008-12-11T14:43:00.000-06:00

Asbestosis-Related Years of Potential Life Lost Before Age 65 Years --- United States, 1968--2005

Exposure to asbestos fibers can cause asbestosis and other diseases (1) after a latency of 10--40 years from initial exposure to onset of illness. Asbestos still is used in the United States (approximately 2,200 metric tons in 2006) in certain products manufactured domestically (2). In addition, an undocumented amount of asbestos continues to be imported in products manufactured elsewhere, and a substantial amount of asbestos remains in existing buildings and manufactured products. An estimated 1.3 million construction and general industry workers in the United States potentially are exposed to asbestos each year, mainly from manipulation of asbestos during renovation or demolition activities (3). Also, although asbestos ore is no longer mined in the United States (4), some U.S. mine workers might remain at risk for exposure to asbestos contained in other ores. To characterize trends in premature mortality attributed to asbestosis in the United States, CDC analyzed annual underlying cause-of-death data for 1968--2005, the most recent years for which data were available.* This report describes the results of that analysis, which indicated that annual years of potential life lost before age 65 years (YPLL) attributed to asbestosis increased 64%, from an average of 146.0 YPLL per year during 1968--1972 to 239.6 per year during 2001--2005 (regression trend for the 5-year moving average, p<0.001), for an overall total of 7,267 YPLL (mean per decedent: 6.2) over the entire period. These results demonstrate that asbestosis-attributable YPLL continue to occur and that efforts to prevent, track, and eliminate asbestosis need to be maintained.

For this analysis, decedents for whom the International Classification of Diseases (ICD) code for asbestosis was listed as the underlying cause of death were identified from 1968--2005 mortality data.? Given the occupational etiology and long latency of asbestosis, analysis was restricted to deaths of persons aged >25 years. Standard industry and occupation information that met CDC quality criteria was available for decedents in 26 states during the 1985--1999 period.§ After 1999, funds for coding industry and occupation were not available, and coding at the state level ceased. The number of states reporting data in any particular year varied from 16 to 22, and the number of years of data available for any one state varied from 2 to 15. Industry and occupation were classified according to two U.S. Census Bureau coding systems.¶ YPLL and mean YPLL were calculated using 5-year age groups and standard methodology (5). A simple linear regression model was used for time-trend analysis of YPLL (using 5-year moving averages).

During 1968--2005, asbestosis was identified as the underlying cause of death for 9,024 decedents. Of these, 1,169 (13.0%) were aged 25--64 years, including one (0.1%) decedent aged 25--34 years; 17 (1.5%) aged 35--44 years; 165 (14.1%) aged 45--54 years; and 986 (84.3%) aged 55--64 years, accounting for 7,267 YPLL (mean per decedent: 6.2). The majority of asbestosis decedents aged 25--64 years were male (1,125 [96.2%]) and white (1,064 [91.0%]), accounting for 7,038 (96.8%) and 6,470 (89.0%) YPLL, respectively (Table 1).

YPLL attributed to asbestosis deaths increased 64%, from an average of 146.0 per year during 1968--1972 to 239.6 per year during 2001--2005 (regression trend, p<0.001). YPLL varied annually, from a low of 69 (mean per decedent: 8.6) in 1973 to a high of 306 (mean per decedent: 5.9) in 1990 (Figure). The rate varied annually, from a low of 0.73 per million in 1973 to a high of 2.78 per million in 1970. During 1968--2005, asbestosis deaths in Texas (85; 577 YPLL), Pennsylvania (99; 544 YPLL), New Jersey (90; 527 YPLL), and California (76; 468 YPLL) accounted for 29.9% of all decedents aged 25--64 years with asbestosis as the underlying cause of death and 29.1% of the total YPLL attributed to asbestosis (Table 1).

Industry and occupation information was available for 153 (28.8%) of the 531 decedents aged 25--64 years with asbestosis as the underlying cause of death during 1985--1999 (Table 2). Of 54 industries reported, the greatest YPLL were in construction (244 YPLL; mean per decedent: 5.7); ship and boat building and repairing (41; mean per decedent: 5.9); and military (41; mean per decedent: 5.9). Of 59 occupations reported, the greatest YPLL were for insulation workers (112; mean per decedent: 5.9); managers and administrators, not elsewhere classified (43; mean per decedent: 7.2); and plumbers, pipefitters, and steamfitters (42; mean per decedent: 4.7).

Reported by: JM Mazurek, MD, JM Wood, MS, Div of Respiratory Disease Studies, National Institute for Occupational Safety and Health, CDC.

Editorial Note:
YPLL are a measure of premature mortality that emphasizes deaths occurring among younger persons during their most productive years (5,6). Persons dying before age 65 years are considered as having years of potential work tenure lost, on the assumption that these are a worker's most productive years. During 1968--2005, asbestosis was identified as the underlying cause of death for 1,169 decedents aged 25--64 years, accounting for 7,267 YPLL. Overall, a mean of 6.2 YPLL per decedent was attributed to asbestosis during 1968--2005, indicating that, on average, decedents aged 25--64 years with asbestosis listed as the underlying cause of death died at age 58 years. Despite the decline in asbestos use and reduced exposures, the findings described in this report indicate that asbestosis-attributable YPLL continue to occur. Because asbestosis mortality typically manifests several decades after initial exposure to asbestos, much of the continuing YPLL likely is attributed to exposures experienced decades ago. During 1970--2004, the annual number of asbestosis-related deaths (based on the analysis of asbestosis deaths coded on the entity axis in multiple cause-of-death files**) in the United States increased nearly 17-fold, from 89 (age-adjusted death rate: 0.6 per million persons aged >15 years) in 1970 to 1,493 (6.9) in 2000, and then declined slightly to 1,470 (6.3) in 2004, for an overall total of 25,413 asbestosis deaths over the entire period (7). This slight decline in the age-adjusted death rate was attributed to several factors, including reduced use of asbestos and improved control of asbestos exposure (8,9). Beginning several decades ago, increased awareness of the health consequences of asbestos exposure stimulated voluntary and regulatory actions by the Environmental Protection Agency and the Occupational Safety and Health Administration (8,9).

Available data (for 153 decedents) indicated that the greatest industry-specific YPLL values were associated with work in construction and ship and boat building and repairing, which is consistent with documented past industry-specific asbestos exposures (1). Likewise, two of the three occupations with the greatest YPLL values, insulation workers and plumbers, pipefitters, and steamfitters, are well known to have been associated with asbestos exposures.

The findings in this report are subject to at least six limitations. First, this report used a death certificate--based definition of asbestosis as the underlying cause of death. Because some deaths from asbestosis might have been attributed to other diseases (e.g., idiopathic pulmonary fibrosis) instead of to asbestosis, the findings in this report likely underestimate deaths and YPLL attributable to asbestosis. Second, complete work histories are not listed on death certificates, and the relevance of the reported usual industry and occupation to actual hazardous exposures could not be verified. Although no studies have examined the accuracy of usual industry and occupation information on death certificates specifically for asbestosis decedents, research suggests a generally good agreement of this information compared with that from other sources (10). Third, coded information on usual industry and occupation were available for decedents in only 26 states, accounting for 28.8% of all U.S. asbestosis decedents during 1985--1999. Thus, these data might not be nationally representative for 1985--1999. Fourth, the state issuing a death certificate is not always the state in which the decedent's asbestos exposure occurred. Fifth, ICD cause-of-death codes used in this analysis changed twice during 1968--2005. However, these revisions likely did not introduce bias or affect the temporal trend in asbestosis deaths (7). Finally, YPLL, as calculated, do not account for the full burden of asbestosis. During the period for which CDC analyzed U.S. death data, approximately 87% of the deaths with asbestosis listed as the underlying cause of death occurred in persons aged >65 years. Moreover, although YPLL do reflect premature mortality during the most productive years of life, YPLL do not account for all reduced quality of life or work years lost attributed to disability from asbestosis. Persons with asbestosis can live for many years with severely limited lung function and few treatment options, leading to inability to work.

The continuing occurrence of cases of asbestos in younger persons (asbestosis-attributable YPLL) underscores the need for persistent asbestosis prevention and elimination efforts. Effective primary prevention is critical because asbestos-related diseases can develop or progress even after occupational exposure ends. Guidance for persons concerned about exposure to asbestos and for health-care providers who work with patients potentially exposed to asbestos is available at http://www.cdc.gov/health/asbestos.htm. CDC continues to conduct surveillance for asbestosis and other asbestos-related deaths to follow trends and identify problems.

Acknowledgments

This report is based, in part, on contributions by RM Castellan, MD, and PJ Middendorf, PhD, National Institute for Occupational Safety and Health, CDC.
References

   1. Rom WN. Asbestos-related lung disease. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, eds. Fishman's pulmonary diseases and disorders. 4th ed. New York, NY: McGraw-Hill Medical; 2008:943--58.

   2. Kelly TD, Matos GR. Historical statistics for mineral and material commodities in the United States: US Geological Survey data series 140. Reston, VA: US Geological Survey; 2007. Available at http://minerals.usgs.gov/ds/2005/140.

   3. US Department of Labor. Better protection against asbestos in the workplace. Fact sheet no. OSHA 92-06. Available at http://www.pp.okstate.edu/ehs/training/oshasbes.htm.

   4. Van Gosen BS. Reported historic asbestos mines, historic asbestos prospects, and natural asbestos occurrences in the eastern United States. US Geological Survey open-file report 2005--1189. Reston, VA: US Geological Survey; 2006. Available at http://pubs.usgs.gov/of/2005/1189.

   5. Wise RP, Livengood JR, Berkelman RL, Goodman RA. Methodological alternatives for measuring premature mortality. Am J Prev Med 1988;4:268--73.

   6. CDC. Premature mortality in the United States: public health issues in the use of years of potential life lost. MMWR 1986;35(2 Suppl):1S--11S.

   7. Bang KM, Mazurek JM, Syamlal G, Wood JM. Asbestosis mortality surveillance in the United States, 1970--2004. Int J Occup Environ Health 2008;14:161--9.

   8. US Environmental Protection Agency. EPA asbestos materials bans: clarification. Available at http://www.epa.gov/oppt/asbestos/pubs/asbbans2.pdf.

   9. Martonik JF, Nash E, Grossman E. The history of OSHA's asbestos rule makings and some distinctive approaches that they introduced for regulating occupational exposure to toxic substances. AIHAJ 2001;62:208--17.

10. Steenland K, Beaumont J. The accuracy of occupation and industry data on death certificates. J Occup Med 1984;26:288--96.

* Since 1968, CDC's National Center for Health Statistics (NCHS) has compiled multiple cause-of-death data annually from death certificates in the United States. CDC's National Institute for Occupational Safety and Health (NIOSH) extracts information on deaths from occupationally related respiratory diseases and conditions from the NCHS data and stores the information in the National Occupational Respiratory Mortality System (NORMS), available at http://webappa.cdc.gov/ords/norms.html.

? ICDA-8 code 515.2 (asbestosis) for years 1968--1978, ICD-9 code 501 (asbestosis) for years 1979--1998, and ICD-10 code J61 (pneumoconiosis due to asbestos and other mineral fibers) for years 1999--2005. For years 1999--2005, decedents with ICD-10 underlying cause coded as J65 (pneumoconiosis associated with tuberculosis) or J92.0 (pleural plaque with presence of asbestos) also were included in the underlying cause-of-death tabulation for asbestosis if code J61 also was listed on the death certificate.

§ Alaska, Colorado, Georgia, Hawaii, Idaho, Indiana, Kansas, Kentucky, Maine, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Washington, West Virginia, and Wisconsin.

¶ Industry and occupation information from death certificates was coded on the NCHS multiple cause-of-death data files according to the 1980 U.S. Bureau of Census Index of Industries and Occupations classification system from1985 to 1992, and according to the 1990 U.S. Bureau of Census classification system from 1993 to 1999. For the industries and occupations listed in this report, the 1980 and 1990 classification system codes and titles were the same.

** Entity axis includes information on all of the diseases, injuries, or medical complications, as well as the location (part, line, and sequence) of the information recorded on each death certificate. "Detail Record Layout" available at http://www.cdc.gov/nchs/about/major/dvs/mcd/1998mcd.htm.

Original article is located here: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5749a1.htm

Study Investigates Link Between Genetic Predisposition and Mesothelioma Cancer

2008-11-27T23:21:00.000-06:00

LegalView Reports Results of a Breakthrough Study Investigating Link Between Genetic Predisposition and Developing Mesothelioma Cancer

LegalView informed readers to the results of a scientific investigation studying the potential link between genetic components and developing mesothelioma cancer. Scientists determined that genetic responses occurred after a specific type of asbestos was introduced to cells within the lining of the lungs.

Denver, CO, September 01 -- LegalView.com, the number one legal resource available on the Web, offered updated details on its mesothelioma information blog of an advanced scientific investigation studying the link between asbestos and genetics. Researchers, who found a genetic response to a specific type of asbestos known as crocidolite, published their findings in an August 2008 issue of BMC Genetics. The study, a first of its kind, used a methodology of exposing cells within the human lung lining to asbestos and then scientists watched the reaction and changes. The study offers mesothelioma victims a unprecedented look into how asbestos affects the human body. Victims were also provided with a gleam of progress on finding a cure for the condition, although the scientists stated more research is required.

Individuals who are suffering from an asbestos-related disease are advised to contact a mesothelioma law firm that can provide access to a wealth of knowledgeable mesothelioma attorneys. Because mesothelioma cancer is incurable and is commonly considered a preventable illness, discussing the details of a potential mesothelioma lawsuit with a mesothelioma lawyer may provide insight as to how monetary compensation could be awarded to aid in the costly medical bills associated with mesothelioma.

In their study, the researchers reported that asbestosis occurs in nearly 200,000 individuals each year with an additional 4,000 asbestos-related deaths occurring annually as well. Asbestos is a type of mineral that was mined for use in insulation because of its fire-retardant qualities and inexpensive production costs. However, inhaling asbestos fibers has led to a severe and incurable form of lung cancer known as mesothelioma. Millions of Americans may have been exposed to asbestos fibers during the 20th century, as asbestos was heavily mined and often used during the construction of buildings such as elementary schools, universities, hospitals, office buildings, homes and apartments.

In addition to mesothelioma information, LegalView houses a library of other legal issues potentially causing harm to everyday Americans. Also, due to the ongoing crisis among the pharmaceutical community, LegalView has provided updated information on several pharmaceutical drug's side effects and dangers. Among the drugs are Ketek as well as Levaquin and Cipro, both of the fluoroquinolone family.

Ketek (telithromycin) is an antibiotic used to treat conditions such as community-acquired pneumonia, bronchitis, sinusitis and other upper respiratory infections. The antibiotic is manufactured by Sanofi-Aventis and has been available to the market since 2004, however, since its release, the U.S. Food and Drug Administration (FDA) has reported nearly 20 deaths of individuals consuming the medication. The deaths all involved the development of liver damage among the patients who died as well as an additional 100 patients who also reported signs and symptoms of liver disease while taking Ketek. Those who have consumed Ketek and feel they exhibit any of the side effects commonly associated with liver disease, such as jaundice or yellowing of the skin, should seek medical assistance immediately. Additionally, it may be advisable for an individual to be involved with a Ketek class action lawsuit and contacting an experienced pharmaceutical lawyer will assist with any legal action necessary.

Levaquin (levofloxacin) and Cipro (ciprofloaxacin), similar to Ketek, are also antibiotics that treat bacterial infections such as bronchitis, although, in July 2008 the FDA gave all of the fluoroquinolone drugs an increased warning label known as the "black box" warning label, the harshest warning given by the FDA. The warning label was increased because the Levaquin and Cipro risks had been previously linked to tendon rupture among patients, according to several studies including one published in Clinical Rheumatology in February 2004. The black box warning is to encourage physicians to avoid prescribing these drugs to patients who may be at a greater risk for Achilles tendon rupture, including elderly patients.

LegalView provides a vast array of resources for individuals plagued by legal misfortune so that they may positively improve their situation and have the tools necessary to do so, including the recently updated Zimmer Durom cup information portal. The Zimmer Durom cup is an artificial hip component used during hip replacement surgery among patients. However, Zimmer Holdings, manufacturers of the product, recently halted the production of the hip socket after hundreds of doctors complained that the medical device was failing among patients. To learn more about the potential for a Zimmer Durom cup recall, visit the LegalView homepage at http://www.LegalView.com/.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com
www.legalview.com

Mesothelioma Treatment Video
Bengoshi-san
Accident Injury Compensation

Asbestos Line is Now Hot

2008-11-14T19:06:00.000-06:00

The Asbestos Hotline is Now Launched and Online

Environmental Control Services has announced the official launch of TheAsbestosHotline.com, an informational website about asbestos that is totally free to the public.

Ashland, KY, November 01, 2008 -- Environmental Control Services, Inc. has announced the launch of their new website, TheAsbestosHotline.com. President & CEO, David Runyon has taken over 20 years of experience in the asbestos consulting, testing, and training field and created this very informational website that includes an online tutorial about asbestos, health effects, uses of the mineral, etc. TheAsbestosHotline is totally free to the public.

Mr. Runyon has worked in the asbestos field since 1986 and has extensive experience in the identification of asbestos containing materials, bulk material sampling, air monitoring, abatement design, and abatement project management. He has conducted hundreds of inspections in schools and commercial buildings as well as conducting asbestos awareness training for school system employees since the Asbestos Hazard Emergency Response Act (AHERA) came into effect in 1989. Mr. Runyon also served on the Board of Directors of the West Virginia Environmental Council and was a member of an advisory council that reviewed and made recommendations for the development of the West Virginia State Asbestos Regulations.

TheAsbestosHotline.com also allows users to easily locate asbestos attorneys, abatement contractors, and asbestos inspectors in their state. There can be hundreds or in some cases thousands of licensed asbestos professionals in some states. TheAsbestosHotline.com makes it much easier to find the professional needed. Asbestos Attorneys, Lawyers, Asbestos Contractors, and Asbestos Inspectors can contact TheAsbestosHotline.com directly by phone or online for listing information.

Founder, David Runyon said about TheAsbestosHotline: "We found throughout the years that some people who have worked around asbestos containing materials in schools, commercial buildings and general industry, have at one time or another, been through an asbestos awareness training course. The vast majority of the people in the USA however, still know very little about asbestos. We also found that a lot of these people had only minimal knowledge about it and some had a lot of misconceptions. That's why we developed an online tutorial About Asbestos on TheAsbestosHotline.com."

Contact Information
Environmental Control Services
Dave Runyon
877-508-9887
daver@yoursafeworkplace.com
http://www.theasbestoshotline.com
Asbestos Attorneys, Contractors, and Inspectors may contact them directly to list your company or firm at 877-508-9887

Nascar Schedules
Tokyo Electronics
Cash For Settlements
West Nile Virus Test

Major Cancer is Now Preventable

2008-10-30T13:56:00.000-05:00

Ads Running Throughout the City Are Alerting New Yorkers That a Major Cancer is Now Preventable

"So Disfiguring, So Preventable," the Message about Oral Cancer that is Dominating the City.

New York, NY, October 30, 2008 -- Preventing oral cancer is the word on the street in New York City, as scores of people are spotting advertisements that are running on hundreds of city buses, inside and out. Oral cancer, which kills twice as many Americans as cervical cancer, is now especially on the rise in young people, women and non-smokers partly due to what is widely suspected to be an oral sex related increase in exposure to the human papilloma virus (HPV). OralCDx Laboratories, a division of Oral Cancer Prevention International, has launched a bus ad campaign, urging people to visit BrushTest certified dentists for this routine screening test. The BrushTest, often compared to the Pap smear for the prevention of cervical cancer, tells patients if any of the common red and white spots that are found in almost everyone's mouth at one time or another are pre-cancerous and need to be removed, long before they have the chance to develop into cancer.

The ad appears on the outside and inside of 450 MTA buses. Simultaneously, a similar ad jointly placed by OralCDx Laboratories and the American Dental Association is running on over 100 MTA buses.

The bus ads will be running until the end of November, leading into the Greater New York Dental Meeting, taking place at The Javits Center starting on November 28.

Oral cancer, one of the most disfiguring cancers, kills about as many Americans as melanoma and twice as many as cervical cancer. Very few cancers are preventable, and OralCDx is on a mission to let people know that oral cancer has recently joined the short list of preventable cancers. The effectiveness and accuracy of the BrushTest is referenced by both the National Cancer Institute and the ADA, and the test is used by over 30,000 dentists nationwide.

About the BrushTest

OralCDx Laboratories, a division of Oral Cancer Prevention International, Inc., is the worldwide, exclusive provider of the BrushTest, utilizing patented and proprietary tissue sampling and cell analysis systems. The BrushTest is used by dentists and physicians to help prevent oral cancer, a disease that kills as many Americans as melanoma, twice as many as cervical cancer, and is rising among women, young people and non-smokers. Well over 25% of those found to have oral cancer do not use tobacco or abuse alcohol. Recent studies have also shown a link between HPV and an increase in oral cancer.

The BrushTest is taught in the majority of U.S. dental schools and is a covered benefit under Medicare, Medicaid and most private U.S. medical and dental insurance plans. The American Dental Association (ADA), in collaboration with OralCDx Laboratories, has recently embarked on a campaign to inform patients that because of the BrushTest, oral cancer has joined the short list of cancers that can now be stopped, years before they can even start. The accuracy of OralCDx was demonstrated in one of the largest studies in oral medicine ever conducted, performed at 35 academic centers in the U.S., involving nearly 1,000 patients. This study was published as the cover story of the Journal of the American Dental Association and earned OralCDx the ADA's prestigious Seal of Acceptance.

For more information on the OralCDx BrushTest, call (877) 672-5722 or visit www.BrushTest.com.

Contact Information

OralCDx Laboratories
Sharon Golubchik
845-368-7451
gsharon@cdxlabs.com
www.oralcdx.com

Employee Performance Management Software
Hearing Aid Repair
Mesothelioma Survival Rates
Product Liability Attorney

Silent Killer of WWII American Veterans

2008-10-01T23:37:00.000-05:00

LegalView Informs Mesothelioma Blog Readers with Details on Asbestos: Silent Killer of American Veterans Dating Back to World War II

LegalView informed mesothelioma blog readers of a silent killer of American soldiers and veterans besides traumatic brain injury (TBI). Mesothelioma cancer has likely affected thousands of American veterans, even dating back to World War II navy veterans.

Denver, CO, August 17, 2008 -- LegalView, the most comprehensive legal resource available on the Internet, unveiled details of a "silent killer" of American veterans that dates back to World War II. Asbestos fibers and dust may have been silently killing veterans returning home from American-fought wars, and has long been overlooked, according to veteran and book author William S. Burton Sr. Currently, many scientists and researchers have deemed traumatic brain injury (TBI) to be the "signature injury" of the recent war, but veterans also suffer from mesothelioma cancer caused by the inhalation of asbestos.

According to Burton, veterans, especially navy veterans from World War II, have had difficulties proving their asbestos-induced conditions to the Department of Veterans Affairs (VA). Veterans as well as those suffering from the cancer are encouraged to locate a mesothelioma law firm that can provide a plethora of experienced mesothelioma attorneys to choose from.

Mesothelioma cancer is caused by inhaling asbestos fibers, which were mined throughout the world in the 20th century. Tremolite, which is found in asbestos, caused fibers being inhaled to line the inside of the lung causing the deadly form of cancer that can spread to other parts of the body. While much is being done to find out about mesothelioma treatment, there are no known cures and very few treatments that can offer an increased survival rate. Veterans who suffer from this lung condition should seek medical attention and consult a mesothelioma attorney to learn about receiving medical disability and compensation claims for war-related conditions/illnesses.

For more on mesothelioma cancer visit LegalView's homepage. On this site, find several other various categories to navigate through and locate information on legal topics such as the faulty Zimmer Durom cup or the tendonitis-inducing Levaquin. Also learn the latest on the Viapro recall.

The failing Durom cup hip socket from Zimmer Holdings has stopped being manufactured while hundreds of physicians claim the Durom cup risks have caused failing hip components among some patients, which would likely be cause for an additional hip replacement surgery. The faulty hip socket has already been implanted into approximately 12,000 patients since the components release in 2006.

Levaquin, which is an antibiotic belonging to the fluoroquinolones drug group, was recently issued the harshest label possible by the U.S. Food and Drug Administration (FDA). The black box label is a warning for physicians that the drug includes serious side effects such as the increased risk of tendonitis or tendon rupture among patients. Individuals taking Levaquin are encouraged to contact a pharmaceutical attorney to learn about the details of a Levaquin class action lawsuit.

The ongoing complications associated with Viapro were discovered after an internal investigation and test by the FDA that found an undeclared ingredient in the drug. Viapro, which treats erectile dysfunction (ED) and sexual impotency, has been recalled, but patients may still suffer from the Viapro side effects. Those who are at risk are those also consuming medications containing nitrates, which can be found in high blood pressure, high cholesterol, heart disease and diabetes medications.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com
www.legalview.com

New Clinical Trial Combines Chemotherapy and Radiation

2008-09-11T22:57:00.000-05:00

LegalView Blog Announces Recruitment of Mesothelioma Victims for New Clinical Trial Combining Chemotherapy and Radiation Treatments

LegalView made available the details of a new clinical trial, which will test chemotherapy and radiation methods rather than surgery as a treatment among mesothelioma patients. Victims of mesothelioma cancer are currently being recruited for the study, which will likely last 13 weeks.

Denver, CO - July 12, 2008 -- LegalView, the most comprehensive legal resource available on the Web, released details of a newly advertised clinical trial that will target radiation and chemotherapy treatments rather than surgery for mesothelioma patients. The study is for individuals suffering from malignant pleural mesothelioma, which is often considered the most deadly form of mesothelioma cancer. The trial will take approximately 13 weeks and will involve exploratory surgery as well as chemotherapy and radiotherapy, which will be administered directly into the affected area.

Mesothelioma cancer is caused by the inhalation of asbestos fibers and dust, which can occur anywhere asbestos has been previously used, although it is most commonly found in insulation within the construction industry. Individuals who have been affected by mesothelioma cancer are advised to seek out a mesothelioma law firm that can provide victims with a better understanding of the details of a potential mesothelioma lawsuit. An experienced law firm will also provide a plethora of mesothelioma lawyers to deal with the specifics of an individual's asbestos-related case.

The new clinical trial aims to find a successful alternative treatment to surgery. Currently, mesothelioma cancer has a grim prognosis, as it is usually not successfully treatable and most often the cancerous portions of the lung are removed via a surgical procedure, which doesn't commonly provide a prolonged life for victims. Additionally, according to the details of the study, surgery "may even lead to a worsened pulmonary function" among patients. For more information on developing litigation related to mesothelioma and asbestos, individuals should locate a mesothelioma attorney who can provide legal consultation on the details of an individual victim's lawsuit.

For information on locating an experienced lawyer, visit LegalView's homepage, which also offers additional information on an array of legal topics including the heavily discussed pharmaceutical controversies that have recently threatened patients. For example, prescription drugs such as Levaquin, Avandia and Chantix have become hot topics in many news reports for the alleged side effects and potential risks associated with each drug.

Levaquin is an anti-bacterial prescription drug that is part of the fluoroquinolone drug family. Levaquin is used for an array of conditions ranging from urinary tract infections to bronchitis to gonorrhea and Chlamydia to pneumonia. According to several scientific studies recently released, consumption of the drug may lead to Levaquin-induced Achilles tendonitis among patients who take the drug for short- to long-term periods of time. One study published in the Journal of the American Board of Family Medicine suggested that patients who had taken the drug anywhere from 6 months to two years and prior may even be at risk for the Levaquin tendon rupture. Additionally Cipro, another of the fluoroquinolone drugs, has also been found to pose a potential risk for tendonitis and tendon rupture and has thus been given a "black box" Cipro FDA warning. The "black box warning is the strongest warning the FDA can put on a drug.

Finally, Chantix, one of the most recently released prescription drugs, is used to aid patients attempting to quit smoking. In late 2007, hundreds of patients of the smoking-cessation drug had reported unusual Chantix side effects that included mood swings, erratic behavior, depression, suicidal thoughts and tendencies. An additional 37 cases of suicide among Chantix patients had also been reported to the FDA, according to an FDA Public Health Advisory from 2008. To learn more about these issues as well as many others, visit the LegalView homepage.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

CONTACT INFORMATION
Katie Kelley
LegalView
720-226-6613

Alan Haburchak
legalView
720-226-6613

Cancer Institute Receives Grant to Study Long-term Health Effects of Traumatic Brain Injuries

2008-08-29T23:17:00.000-05:00

John Wayne Cancer Institute Receives Grant to Study Long-term Health Effects of Traumatic Brain Injuries

Research Will Focus on Relationship of Concussion, Pituitary Hormonal Failure and Quality of Life in Retired National Football League Players

SANTA MONICA, Calif.-- July 02, 2008--The John Wayne Cancer Institute at Saint John's Health Center announced today that it has received a grant from the National Operating Committee on Standards for Athletic Equipment to study pituitary hormonal failure (hypopituitarism) in retired football players.

The research, which will be conducted in collaboration with the University of North Carolina's (UNC) Department of Exercise and Sport Science, and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, will be directed by Daniel F. Kelly, MD, director of the Neuro-Endocrine Tumor Center at the John Wayne Cancer Institute, and Kevin M. Guskiewicz, PhD, chairman of the Department of Exercise and Sport Science at UNC.

In a cohort of retired National Football League (NFL) players, the study will examine the relationship between the number of concussions sustained in players' NFL careers, and their subsequent pituitary hormonal function and post-retirement quality of life. The investigators hypothesize that players sustaining multiple concussions are at increased risk of developing pituitary hormonal dysfunction which may in turn contribute to problems of obesity, fatigue, impaired metabolism, depression, sexual dysfunction and a general poor quality of life.

According to Dr. Kelly, the new study will focus on a relatively unexplored area of traumatic brain injury (TBI)-the potential correlation between recurrent concussions and pituitary hormonal dysfunction. More than 1.2 million Americans sustain a TBI annually, the majority of which are cerebral concussions. Repeat concussions have been shown to be a risk factor for neurodegenerative dementing disorders, including mild cognitive impairment and Alzheimer's Disease. However, little is known about the impact of single or multiple concussions on hormonal function and quality of life. Only in the sport of boxing, have a few small studies shown that boxers are at increased risk of developing pituitary failure. In contrast, it is well known that a single severe head injury can lead to pituitary damage and hormonal abnormalities in up to one third of individuals.

The pituitary is a small bean-shaped gland located immediately below the brain and behind the nasal cavity in the skull base; it is connected to the brain by the thin delicate vascular pituitary stalk. Weighing less than one gram, the pituitary is often called the "master gland" since it controls the secretion of the body's hormones. These essential substances when released by the pituitary into the blood stream have a broad range of effects on growth and development, sexuality and reproductive function, metabolism, the response to stress and overall quality of life.

"This research is long overdue," Dr. Kelly said. "Millions of young people and professional athletes participate in sports that put them at risk of concussion; not just football, but also hockey, rugby, soccer, baseball and basketball. We need to know more about how these so-called "minor head injuries" impact their lives in subsequent years, and in particular, whether multiple concussions can lead to pituitary hormonal failure and poor quality of life."

Using the database of the Center for the Study of Retired Athletes at University of North Carolina and in cooperation with the National Football League Players' Association, 90 study participants will be categorized based on the number of concussions they sustained during their NFL career. The retired players will then be assessed utilizing pituitary hormonal blood tests, body composition testing and neurobehavioral, quality of life and sexual function surveys. Retirees found to be deficient in any hormones such as thyroid, testosterone or growth hormone will be treated with physiological replacement doses of the appropriate hormone and will then have repeat quality of life testing. Hormonal testing assays will be conducted by the General Clinical Research Center at Harbor-UCLA Medical Center under the direction of Professor Christina Wang, an endocrinologist and a study co-investigator.

"The problem of sports-related concussions is increasingly recognized as a major contributor to long-term disability in many retired athletes," said Bob Klein, vice president at Saint John's Health Center and a ten-year NFL veteran with the Los Angeles Rams and San Diego Chargers. "However, the potential impact of concussions on quality of life is not well understood. This research will fill that gap in our knowledge. I have spoken with many of my former colleagues in the NFL, and they share my belief in the critical importance of this study."

The Neuro-Endocrine Tumor Center (www.neuro-endo.org) is housed at Saint John's Health Center and the John Wayne Cancer Institute in Santa Monica, California. The Center's focus of activities is the treatment of pituitary tumors, brain tumors, and other neuro-endocrine disorders including pituitary hormonal deficiencies.

The Center for the Study of Retired Athletes at the University of North Carolina works in close affiliation with the National Football League Players Association. Since 2001, the Center has been investigating a spectrum of physical and mental disabilities common to retired athletes. The research team will begin work in July 2008, with initial research results expected in 2010.

Since its founding in 1942 by the Sisters of Charity of Leavenworth, Saint John's Health Center has been providing the patients and families of Santa Monica, West Los Angeles and ocean communities with compassionate, advanced medical care. Saint John's provides a spectrum of treatment and diagnostic services with distinguished areas of excellence in cancer care, cardiac care, orthopedics and women's health. Saint John's Health Center is also dedicated to bringing to the community the most innovative advances in technology and patient care available in a healing environment.

Since 1981, the John Wayne name has been committed by the Wayne family to groundbreaking cancer research in memory of the much-loved actor who died of cancer. The John Wayne Cancer Institute has received worldwide acclaim for advances in understanding the disease, focusing on melanoma (skin cancer), breast, prostate, colon, pancreatic, lung and liver cancer, as well as lymphoma and leukemia. With its unique ability to rapidly turn scientific breakthroughs into innovative approaches to treatment and early detection, JWCI provides immediate hope to cancer patients from around the globe.
Contacts

Saint John's Health Center
Greg Harrison, 310/829-8010
858/472-5560 (cell)
gregory.harrison@stjohns.org

Mesothelioma Survival Rates Among Patients Taking New Treatment

2008-08-25T22:33:00.000-05:00

LegalView Recounts the Results of a Recent Mesothelioma Study That Reported High Survival Rates Among Patients Taking New Treatment

LegalView reported the results of an Italian study to its mesothelioma blog readers; the results detailed a positive outcome and increased survival rate for elderly pleural mesothelioma victims. The study, recently published in a British medical journal, used a combination of two medicinal treatments commonly prescribed separately.

Denver, CO, August 16, 2008 -- LegalView, the most comprehensive legal resource available on the Web, recounted the results of an Italian study to its mesothelioma information blog readers. The study attempted to increase the survival rate of elderly pleural mesothelioma patients by combining two medications: Alimta (pemtrexed) and Paraplatin (carboplatin). The results of the study were released in a June issue of the British Journal of Cancer and the conclusions detailed the highly-effective treatments, which increased the survival rate among pleural mesothelioma patients 65 years of age or older.

Mesothelioma is an incurable cancer that is often attributed to the inhalation of asbestos fibers and dust containing tremolite. Asbestos is a known carcinogen, according to the Environmental Protection Agency (EPA), which is responsible for regulating the cleanup of the hazardous material. Asbestos was often prized for its ability to remain fire-resistant, while being produced cheaply, and served as a key ingredient in many products including insulation that was implemented into homes, apartment complexes, universities, schools, business offices and hospitals around the country. Individuals who suffer from mesothelioma cancer are advised to speak with a knowledgeable mesothelioma attorney in order to better educate themselves on the possibility for developing a mesothelioma lawsuit. Due to the extremely costly medical bills associated with increasing survival rate among mesothelioma cancer victims, developing litigation may result in monetary compensation to assist with those medical bills.

LegalView not only offers resources on the most recent mesothelioma news and clinical trials, but also offers information on a variety of other legal issues afflicting millions of Americans. Most recently, LegalView updated several of its pharmaceutical drug information portals with news on updates and recalls; some of the portals include Viapro, Ketek and the Zimmer Durom cup.

The development of the Viapro information portal occurred after the U.S. Food and Drug Administration (FDA) issued a press release on the recall of the drug because of contamination of a harmful chemical known as thiomethisosildenafil. The male sexual-enhancement prescription drug, manufactured by EG Labs, is used to treat erectile dysfunction (ED). The undeclared ingredient may be harmful to patients especially when interacting with nitrates found in other prescription drugs. The Viapro recall occurred because the drug may cause dangerously low levels of blood pressure among patients also taking nitroglycerin for diabetes, high blood pressure, high cholesterol or heart disease.

Ketek, which is an antibiotic used to treat upper respiratory infections such as pneumonia, bronchitis and sinusitis, had its warning labels increased recently due to the threat of liver disease among patients consuming the drug. To learn more about the Ketek side effects, visit http://ketek.legalview.com/.

Also among the recently updated information portals is that of the Zimmer Durom cup. Zimmer Holdings has ceased production of its Durom cup because of complaints that the hip socket was failing among many patients. Although the company has ceased production of the hip socket, pending internal investigations into the potential failure, the hip socket has already been used in over 12,000 hip replacement procedures since its introduction to the market in 2006. Patients who may be at risk for the Durom cup failure should seek medical attention immediately to ensure no further damage occurs.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information
LegalView
Katie Kelley
720-771-3246
press-releases@legalview.com
www.legalview.com

Industry Makes Request to Decrease Asbestos Regulations

2008-08-19T10:30:00.000-05:00

LegalView Offers Mesothelioma Blog Readers Details of Disconcerting Request to Decrease Asbestos Regulations from Industry

LegalView informed mesothelioma blog readers of an potentially troubling request by automotive, chemical and mining industries' paid researchers to "water down" asbestos regulations. The industry-hired scientists argued that asbestos is no longer as dangerous, even though several international health organizations have declared no safe level of the material.

Denver, CO - August 2, 2008 -- LegalView, the number one resource for everything and anything legal on the Internet, recently updated readers with the latest piece of mesothelioma information, relating to the request by paid researchers for the automotive, chemical and mining industries to decrease asbestos regulations. In a July 2008 summit in Washington D.C., the Environmental Protection Agency (EPA) met with the Office of Solid Waste and Emergency regarding the request. The industry researchers argued that asbestos fibers found in sand, taconite and other materials are less toxic than originally deemed in the 1980s when the regulations were created. However, the EPA along with the International Agency for Research on Cancer, the Occupational Safety and Health Administration (OSHA) and The World Health Organization (WHO) have all determined that no level of exposure to asbestos fibers is safe and the material as well as products using asbestos should be permanently banned.

Asbestos was mined for years and was frequently used in the construction industry for an array of products, most often insulation. However, it was determined that exposure to asbestos fibers causes a deadly form of lung cancer known as mesothelioma. Individuals who suffer from mesothelioma cancer should contact an experienced mesothelioma attorney to receive a legal consultation on the possibility of developing a personalized mesothelioma lawsuit. Because the cancer is fatal and no completely effective mesothelioma treatment exists to reduce the disease it may be important to develop litigation and potentially receive monetary compensation to pay for costly medical bills. Mesothelioma is a dormant condition that can take decades before symptoms reveal themselves, at which point, little can be done to improve the illness.

According to news reports, at the Washington D.C. summit, approximately 83 public health officials signed a 29-page report on the "science-for-hire" practice, which Dr. Michael Silverstein, who wrote the report, alleges is occurring on the part of automotive, chemical and mining industries. The report, opposing the request, urged the EPA to focus on public health rather than big industry and to avoid decreasing the asbestos regulations.

Learn more about this ongoing issue as well as other legal issues through LegalView.com. LegalView continues to maintain a comprehensive library of legal issues; issues that may be causing harm to millions of Americans each year. LegalView recently updated several of its issues to include detailed information and news. Some of the recently updated sites include information on the Zimmer Durom cup, the Ketek antibiotic and Avandia prescriptions.

The Durom cup, manufactured by Zimmer Holdings, is an artificial hip component that has been under fire by physicians who have said the device is failing their patients. Because of the alleged Zimmer Durom cup risks, the company has ceased manufacture of the hip socket. However, since production began in 2006, nearly 12,000 patients received the cup and may be affected by the failing hip socket and should contact a knowledgeable attorney for advice about the potential Durom cup recall.

Ketek is a pharmaceutical prescription antibiotic that is used to treat upper respiratory infections including pneumonia or bronchitis. Reports have tied the antibiotic with the possibility of severe liver damage among patients. Additional Ketek side effects may also be considered dangerous and those who report signs of yellowing skin or jaundice should consult a doctor immediately

The Avandia portal is continually being updated to provide the public with extensive research, scientific findings and experienced attorney links. Avandia is a prescription drug used to treat type 2 diabetes, which currently affects millions of individuals in the United States. Recent research, however, has found a disturbing link between the use of Avandia and an increase of heart disease as well as osteoporosis among patients. Individuals who feel they may have symptoms relating to heart disease or who have suffered from a bone fracture likely induced by the Avandia side effects, should speak with a medical expert immediately. Additionally, it is advisable to locate an experienced pharmaceutical law firm in case legal advice is necessary for an Avandia settlement.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

CONTACT INFORMATION
Katie Kelley
LegalView
720-226-6613

Alan Haburchak
LegalView
720-226-6613

Predicted Increase in Female Mesothelioma Victims

2008-08-06T23:34:00.000-05:00

LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims

LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause.

Denver, CO - July 21, 2008 -- LegalView, the most comprehensive legal resource on the Web, reported on its mesothelioma information blog a potential increase of mesothelioma cancer victims within the next few years, particularly among women, according to researchers. In 1979, the U.S. Consumer Product Safety Commission (CPSC) released information regarding 26 companies and manufacturers of hand-held hair dryers that had been made with asbestos. While the 26 companies had voluntarily taken action to correct the asbestos-containing hair dryers, individuals who had used the tainted hair dryers may be at risk for developing mesothelioma and should consider contacting a mesothelioma lawyer for information on the development of a potential mesothelioma lawsuit.

Mesothelioma is a deadly form of lung cancer that is caused through the inhalation of asbestos fibers. While asbestos was largely used in the construction industry, commonly within insulation, it has also been used in other products including hair dryers. While the hair dryers were corrected and became asbestos-free nearly 30 years ago it is common for mesothelioma to remain dormant for years and even decades, which is why researchers are concerned with a new group of individuals becoming afflicted by mesothelioma and symptoms becoming prevalent now. Researchers are also particularly concerned for women because women allegedly use hair dryers more than men. To learn more about developing litigation, contact a mesothelioma law firm or mesothelioma attorney to better understand the potential for developing an asbestos-related lawsuit and receiving monetary compensation for the costly bills usually associated with a mesothelioma cancer diagnosis.

In addition to information on mesothelioma, LegalView also offers details on a plethora of other legal issues afflicting millions of Americans each year. For example, readers can learn about the latest fluoroquinolones black box warning labeling. Fluoroquinolones are a group of antibiotics that have become increasingly at risk for severe side effects. Of the fluoroquinolones group, the most commonly prescribed drugs are Levaquin and Cipro. Levaquin, also known as levofloxacin, is manufactured by Ortho-McNeil and treats bacterial infections, specifically treating infections such as skin infections, chronic bacterial prostates, urinary tract infections, pneumonia, bronchitis and acute pyelonephritis caused by Escherichia coli (E. coli). The drug, which was released in 1996, has been the center of numerous clinical trials and studies because of the possible Levaquin side effects, which can include the most serious - Achilles tendon rupture - as well as jaundice, seizures, hallucinations, abdominal tenderness and limb numbness.

Similar to Levaquin is Cipro (ciprofloxacin) from Bayer A.G., which was approved for market use in 2000 and is used to treat bacterial infections similar to those treated by Levaquin. The Cipro risks are the same as Levaquin, which is an increased risk of tendonitis. Additionally, Cipro has other side effects that may also be harmful to patients. Some of the side effects include seizure, difficulty breathing, depression, suicidal thoughts, blacking out and hallucinations.

LegalView also has information on other controversial prescription drugs including Avandia. Avandia is a type 2 diabetes drug that has recently been linked to severe risks among patients. The Avandia dangers may include an increased risk of heart failure as well as a higher risk of developing early onset osteoporosis. Patients who may have developed either of these side effects while taking Avandia should speak with an experienced pharmaceutical lawyer to better understand the potential for developing a potential Avandia lawsuit.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Government Rejects Request to Clean up Asbestos

2008-07-27T17:05:00.000-05:00

LegalView Reports About the Government's Rejection of a Monetary Request to Clean up An Asbestos-Tainted Site

LegalView updated its mesothelioma blog to include news of the government denying federal funds to an area in Arkansas that was left tainted with asbestos after nearly 150 World War II structures were destroyed in a fire. The government rejected the requests from the town of Chaffee Crossing where citizens are currently at risk of contracting mesothelioma cancer.

Denver, CO - LegalView.com, the number one resource for everything legal on the Web, recently reported on its mesothelioma blog that federal funds were denied to cleanup an asbestos-tainted town in Arkansas. Chaffee Crossing is the site of a recent fire, which destroyed nearly 150 World War II (WWII) structures, releasing asbestos fibers and dust into the area potentially increasing the risk of citizens developing mesothelioma. The city requested federal funds from the government to assist the cleanup of the town, which is considered by several citizens there to be a Superfund Site. The Environmental Protection Agency (EPA) is refusing to deem the site a Superfund because it claims that levels of asbestos in the air after the fire were too low to be deemed as such. However, the Arkansas Department of Environmental Quality found asbestos contamination in some areas to be much higher than EPA tests recorded. For those who live in the area or who have previously been exposed to asbestos, using LegalView's mesothelioma portal to locate a mesothelioma attorney is the best way to protect oneself.

Asbestos is a material that is derived from vermiculate, a mineral often mined for uses in construction and as building insulation. Asbestos was widely used as insulation in many early 20th Century constructions, such as those burned in Chaffee Crossing. However, after discovering the link of inhaling asbestos to an incurable form of lung cancer, the use of asbestos was discontinued and the EPA has spent billions of dollars in the removal of asbestos across the country. Individuals who have been exposed to asbestos are advised to contact an experienced mesothelioma law firm to receive an attorney consultation on developing a mesothelioma lawsuit in which compensatory damages can be sought. Mesothelioma is a painful and deadly illness that takes decades to reveal itself, by which time it can be too late to find ways in paying for medical expenses. Use the mesothelioma portal to learn more about this and other recent asbestos-related news.

Additionally, LegalView offers several other information portals relating to a range of issues such as the Baxter Heparin recall, traumatic brain injury (TBI) treatments and Erb's Palsy jury verdicts. Heparin is a blood thinner injected into patients undergoing heart surgery or similar procedures. It is used to prevent blood clots, which can be fatal during surgery. Recently, the Baxter Healthcare Corporation issued a Heparin recall because several patients had reported severe allergic reactions to the drug, which has been associated with at least 19 patient deaths. LegalView.com reported updates continually to readers as this story unfolded, providing insightful and imperative news for victims of the Heparin recall. Similarly, individuals can use the TBI practice area to learn the most up-to-date news on brain injury lawsuits, jury verdicts, treatments as well as how to locate brain injury lawyers.

For information on Erb's Palsy, a condition that usually develops because of labor complications, visit Erb's Palsy lawsuit as the condition is usually preventable and caused by a physician pulling on a baby during birth.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://mesothelioma.legalview.com

Foundation Funds Follow-up Care in Revolutionary Cancer Vaccine Study

2008-07-27T12:51:00.000-05:00

Onyx and Breezy Foundation Funds Follow-up Care in Revolutionary Cancer Vaccine Study

The Onyx & Breezy Foundation recently funded after-care for dogs engaged in a revolutionary research study to develop a cancer vaccine that may be given to both humans and animals when successful. The study is being conducted at The Matthew J. Ryan Veterinary Hospital, a small animal teaching hospital affiliated with the University of Pennsylvania in Philadelphia.

Tuxedo Park, NY and Philadelphia, PA - March 14 -- The Onyx & Breezy Foundation has announced a gift to The University of Pennsylvania School of Veterinary Medicine. The gift will cover the expense of follow-up care for 12 dogs that are currently enrolled in the School's cancer vaccine study.

"Thanks to this generous gift, more participants in our lymphoma cancer vaccine clinical trial will be able to return for follow-up care," said Dr. Karin Sorenmo, chief of oncology at the Matthew J. Ryan Veterinary Hospital. "This means that we can capture all the data that is needed for the study while pet owners are helped financially."

Prior gifts to The Matthew J. Ryan Veterinary Hospital from the Foundation have been a respirator for their ICU department and a mast cell tumor research study.

Dr. Sorenmo treated Breezy, who had mast cell tumors. "Thanks to Dr. Sorenmo, Breezy lived another 2 years, of quality life, after other vets gave her only 6 weeks to live," said Wanda Shefts. "We are glad that this project will help owners of dogs in remission from lymphoma and help advance Dr. Sorenmo's work on the cancer vaccine.

Dr. Sorenmo stated that she was encouraged by the results and she is hoping that this is just the beginning of more trials that can benefit dogs and ultimately help people. Thanks to this study, a number of the participating dogs are now cancer free. The researchers now estimate that they are within two years of testing the vaccine on humans. Without the dogs, they would be more than a decade away.

"We have a tremendous amount of respect for the work they do at the Hospital and we are glad to be able to fund another project for them", said Mark Shefts.

For more information about Penn Vet, please visit www.vet.upenn.edu; for more information about The Onyx and Breezy Foundation, please visit www.onyxandbreezy.org.

The Onyx and Breezy Foundation Background

The Foundation was created in 2004 and named after the trustees Mark & Wanda Shefts' two Labrador Retrievers. The Foundation lends financial support to organizations that benefit the welfare of animals.

The University Of Pennsylvania School Of Veterinary Medicine Background

Penn's School of Veterinary Medicine is one of the world's premier veterinary schools. Founded in 1884, the School was built on the concept of Many Species, One MedicineTM. The birthplace of veterinary specialties, the School serves a distinctly diverse array of animal patients, from pets to horses to farm animals.

Press Contact: Barbara Kauffman
Company Name: The Onyx & Breezy Foundation
Phone: 201-782-7400
Website: www.onyxandbreezy.org

Baxter Heparin Information on Additional Heparin Recall

2008-07-09T10:32:00.000-05:00

LegalView Expands Baxter Heparin Information Portal to Include Information on an Additional Heparin Recall

LegalView updated its Baxter Heparin information portal to add information on the most recent recall of the blood-thinning drug. Heparin, which is used to control blood during surgical procedures, was recently discovered to have a Heparin-like contaminant that sickened many and caused at least 19 deaths.

Denver, CO - March 31, 2008 -- The Baxter Heparin practice area on LegalView's site, the source for everything legal on the Web, was recently expanded to explain details of an additional Heparin recall . Heparin has been linked to hundreds of allergic reactions among patients as well as having been connected with 19 deaths. B. Braun Medical Inc. issued the most recent recall of Heparin, which was supplied from Scientific Protein Laboratories - the same company that supplied Baxter Healthcare Corporation with the contaminated Baxter Heparin. According to the U.S. Food and Drug Administration (FDA) and B. Braun Medical Inc., no one was reportedly sickened off of the Heparin from B. Braun Medical but it did have a "heparin-like contaminant," which was enough for the company to recall the drug.

Heparin is blood-thinner injected into patients who are undergoing surgical procedures such as heart disease or kidney dialysis. It is a drug that has been imported to the United States since the 1930s and is derived from pig intestines. Many surgeons find that Heparin is an extremely important drug because it prevents blood clots from forming during surgery, which can result in death among patients. However, earlier this year, a rash of individuals who had been given Heparin during a surgical procedure had allergic reactions. Individuals who have been affected by the contaminated Heparin should consider contacting a Heparin lawyer to learn about developing a Heparin class action lawsuit for which compensation may be derived from manufacturers if the tainted drug.

The Baxter Heparin that was initially recalled had been tainted with a chemical known as over-sulfated chondroitin sulfate. Through an FDA investigation, it was discovered that a Chinese company that produces the drug was responsible for the tainted Heparin. Although an investigation continues to be ongoing as to whether the chemical was intentionally or accidentally introduced into a batch of the Heparin. According to news reports, using the over-sulfated chondroitin sulfate allows for a reduction in the production of production for Heparin.

For information on additionally recalled prescription drugs or to report an adverse reaction to a prescribed drug, visit LegalView's many unsafe drugs information portals. Here, readers will find information on recently recalled drugs as well as prescription drugs under investigation such as Chantix, Avandia and Trasylol Aprotinin.

Chantix is a smoking cessation drug from Pfizer that was first introduced to the market, with FDA approval, in mid-2006. However, in late-2007 the FDA began an investigation into nearly 400 reports of suicidal tendencies and behaviors among patients. Additionally, nearly 37 suicides have been associated with the Chantix side effects, which include psychotic episodes, depression, suicidal thoughts and erratic behavior.

Avandia is a prescription drug used to treat diabetes 2 among patients; however, the drug has been linked to several serious side effects including an increased risk of heart disease and a higher chance of early onset osteoporosis. Individuals who are taking Avandia are advised to locate an experienced pharmaceutical law firm to receive consultation on an Avandia lawsuit.

Trasylol, also known as its generic version Aprotinin, is similar to Heparin in that it is used during surgical procedures to control blood loss. A study was released in 2006 from the New England Journal of Medicine, which found that the use of Trasylol Aprotinin increased the chances of a patient developing heart disease, kidney disease, stroke and death. Patients who received or may have received Trasylol or it's generic version should use LegalView's information portal to find an Trasylol attorney.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://baxter-heparin.legalview.com

Asbestos Contaminated Housing Project Crews Hid Asbestos Leak

2008-07-06T21:13:00.000-05:00

LegalView Releases News on Asbestos Contaminated Housing Project Where Crews Hid Asbestos Leak with Dirt

LegalView reported on its mesothelioma blog about an asbestos contamination that occurred in Miami during the construction of an affordable housing project. The project, now likely to cost five times the original estimate, was contaminated after crews clearing the area hid an asbestos leak with piles of dirt.

Denver, CO - April 12 -- LegalView.com updated its mesothelioma blog with reports of an asbestos contamination that was concealed with piles of dirt by construction crews who were clearing the area for an affordable housing project. The contamination not only increased the risk of exposure to asbestos and thus development of mesothelioma for individuals in the area, but increased the cost of the affordable housing project by five times the originally estimated amount. Individuals living in the area may have been exposed to asbestos fibers and are urged to contact a medical professional as soon as possible. Additionally, Americans who may have been exposed to asbestos should also contact an experienced mesothelioma law firm.

Asbestos is derived vermiculite, a mineral that was heavily mined in the 20th Century. Asbestos was prized for its ability to insulate buildings with a decreased risk of catching fire. It was used for all types of constructions including schools, offices, homes and apartment buildings. However, after discovering that asbestos exposure caused a deadly lung disease among exposed individuals, mining stopped and the Environmental Protection Agency (EPA) was charged with the task of cleaning up any asbestos. Mesothelioma cancer, which is an untreatable form of lung cancer, is often the outcome for individuals who were previously exposed to asbestos. Those who feel they are at risk for this illness should locate an attorney to explore the possibility of a mesothelioma lawsuit.

The area known as North Miami's Pioneer Gardens was expected to house 136 units for low-income individuals. However, when a contractor began digging, it was discovered that workers who had previously cleared the site had inadvertently caused an asbestos leak when underground pipes containing the contaminant were broken. The workers allegedly covered the leak with piles of dirt and it was left until just recently when digging began. It can take years to develop the cancer and even then a mesothelioma diagnosis is often overlooked, causing the cancer to spread among its victim. To learn about the potential for monetary compensation, individuals are advised to contact an experienced mesothelioma lawyer for an attorney consultation on their individual case.

Other issues that are covered on LegalView's Web site, which have largely negatively impacted thousands of Americans recently, include several prescription drugs - Chantix, Singulair, as well as Vytorin and Zetia. Chantix is a smoking cessation drug that is prescribed to millions of Americans struggling to quit their tobacco addiction. In late 2007, the U.S. Food and Drug Administration (FDA) began receiving reports from patients taking Chantix that the drug was linked with instances of depression, erratic behavior and suicidal tendencies and thoughts. Overall, nearly 400 individuals reported this behavior and the drug was also allegedly linked to 37 suicides among patients. The FDA quickly began investigating the drug and are currently studying the Chantix side effects to determine the drug's dangers.

Similar to the dangerous side effects that have been associated with Chantix, are those that have been linked to Singulair, also a prescription drug, which is given to patients who suffer from severe asthma and allergy symptoms. However, in March 2008, reports began to surface about Singulair's potentially dangerous side effects, which may include mood and behavior changes including suicidal behavior among adults and children. The FDA is currently investigating the Singulair risks that may exist with taking this drug.

Vytorin and Zetia are similar in that both are prescription drugs used to lower cholesterol and prevent heart disease among patients. Often Vytorin and Zetia are used in combination of each other and both are manufactured from Merck/Shering-Plough. Recently, the company made headlines because of an extensive study that was completed in 2006 on the two drugs, which detailed the benefits, or lack thereof, of the medications. However, the Zetia and Vytorin manufacturer allegedly delayed the release of the study to the public because findings that Vytorin and Zetia were not as effective as cheaper alternatives. This information has prompted many patients to consider a Vytorin lawsuit.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://mesothelioma.legalview.com

Sterilisation and Disinfectant Markets in Europe

2008-07-01T12:42:00.001-05:00

Sterilisation and Disinfectant Markets in Europe Enjoy Mixed Fortunes

LONDON-- July 01, 2008 --The sterilisation and disinfectant market in Europe has been witnessing slow growth as hospitals try to tackle alarmingly high infection rates resulting from inadequately decontaminated patient care equipment. However, the market is mature and saturated, offering little scope for technological innovation, and the complete lack of product differentiation is hampering competition. While the disinfection market has shown potential for expansion, the sterilisation market remains largely static.

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Sterilisation and Disinfection Equipment Market, finds that the market earned revenues of over USD269.7 million in 2007 and estimates this to reach USD352.0 million in 2014.

"Though the sterilisation and disinfection equipment market is not characterised by a strong level of technological development, certain mutations are contributing to the overall positive growth," says Frost & Sullivan Research Analyst Kieu A. Vuong. "For instance, slack growth in the low-temperature gas steriliser segments is compensated by positive trends impacting the disinfector equipment sector."

The spurt in the number of surgical procedures utilising minimally invasive instruments such as endoscopes is also driving the need for sophisticated systems for proper disinfection and maintenance of such equipment. This demand for more efficient disinfecting methods is fuelling the growth of the automatic endoscope reprocessor (AER) segment. The washers and AER disinfection markets are exhibiting continuous growth due to advancements in surgical instrumentation and liquid chemical disinfectants as well.

However, emerging trends indicate increasing consolidation and centralisation of hospitals in Europe, drastically reducing the number of hospitals and the number of potential customers. End-user consolidation is a challenge for this market, as purchasing power is augmented.

"High prices along with slow rate of product replacement will force manufacturers to identify different revenue streams in order to maintain and increase their profit margins," notes Vuong. "Despite several attempts at creating a unified platform, insecurities concerning the standardisation and regulation of products continue."

Nonetheless, participants can accrue revenues by providing integrated service packages and proper nurturing of customer relationships, since virtually all hospitals are already equipped with infection control equipment. To achieve the high standards required for service packages, many companies have entered into partnerships to reduce costs and enhance their offering.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European sterilisation and disinfection equipment market, then send an e-mail to Patrick Cairns, Corporate Communications, at pcairns_pr@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

European Sterilisation and Disinfection Equipment Market is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: cardiovascular, wound care, surgical, orthopaedic and others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team MembershipT empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

European Sterilisation and Disinfection Equipment Market

M236

Contacts

Frost & Sullivan
Corporate Communications - Europe & Africa
Patrick Cairns, +27 18 468 2315
patrick.cairns@frost.com
or
Corporate Communications - North America
Stacie Kopecki, 210-247-2450
fax: 210-348-1003
stacie.kopecki@frost.com
or
Corporate Communications - Asia Pacific
Jasminder Kaur, 65-6890-0937
fax: 65-6890-0988
jkaur@frost.com
or
Corporate Communications - South Asia
Remi Chatterjee, +91-44-4001 3419
fax: +91-22-2832 4713
remi.chaterjee@frost.com
or
Corporate Communications - Middle East
Nimisha Iyer, +91 22 4001 3404
fax: +91 22 2832 4713
niyer@frost.com
or
Corporate Communications - China
Amelia Wong, +86 21 5407 5783, ext. 8669
cell: +86 13621724823
amelia.wong@frost.com
or
Corporate Communications - Latin America
José María Jantus, + 54-11-4777-9951
fax: + 54-11-4777-0071
jose.jantus@frost.com
http://www.frost.com

New Patient Safety Solution Supported By Pharmacy Technician Certification Board

2008-06-28T21:14:00.000-05:00

Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution

The Pharmacy Technician Certification Board (PTCB), the leading national program that has certified more than 300,000 pharmacy technicians, supports and congratulates the Florida House of Representatives and Governor Charlie Crist for passing legislation requiring new standards for pharmacy technicians. The new Florida legislation takes a progressive step toward increasing patient safety for consumers. The legislation will ensure pharmacy technicians meet key requirements for training, certification and registration.

Washington, D.C. - June 27, 2008 -- The Pharmacy Technician Certification Board (PTCB) (http://www.ptcb.org/), the leading national program that has certified more than 300,000 pharmacy technicians, is pleased to support and congratulate the Florida Legislature for passing SB 1360 and Governor Charlie Crist for signing it into law, requiring new standards for pharmacy technicians. Tireless advocacy efforts for the passage of this critical patient safety legislation and its final approval by Governor Crist were spearheaded by the Florida Society of Health-System Pharmacists (FSHP) and the Florida Pharmacy Association (FPA).

The new Florida legislation takes a progressive step toward increasing patient safety for consumers. By passing this legislation without amendment, and signing it into law, the Florida state legislature and governor will ensure pharmacy technicians meet key requirements for training, certification and registration. PTCB is proud to have certified 15,000 pharmacy technicians in Florida to date and looks forward to working with more pharmacy technicians and their employers.

"Florida's new pharmacy technician standards are an important patient safety solution for consumers in the Sunshine State and Governor Crist and the state's legislators should be applauded," said PTCB Executive Director and CEO Melissa Murer Corrigan. "To meet these new state standards, PTCB is looking forward to continued work with pharmacy technicians and significant employers of Florida's pharmacy technicians such as Walgreen's, CVS, Publix, Target, the U.S. military, multiple health-systems and independent pharmacists in communities across the state. Several of these employers presently support and endorse PTCB across the United States."

The landmark piece of Florida legislation (SB 1360) contributes to raising the bar for states across the country by providing an example of the high standards needed for pharmacy technicians. The more than 40,000 pharmacy technicians currently working in Florida will be required to register with the Florida Board of Pharmacy by 2010. In 2011, they will need to either complete a board-approved training program with 1,500 hours of work as a technician under a Florida licensed pharmacist, or be certified (https://www.ptcb.org/AM/Template.cfm?Section=Guidebook_to_Certification&Template=/CM/HTMLDisplay.cfm&ContentID=2952) by a program accredited by the National Commission for Certifying Agencies (NCCA). PTCB is the pioneer in certifying pharmacy technicians (https://www.ptcb.org/AM/Template.cfm?Section=Learn&Template=/CM/ContentDisplay.cfm&ContentID=1384) and is accredited by the NCCA. PTCB's certification program has been included in regulations by more than 30 state boards of pharmacy. Through its strategic partnership with Pearson VUE, PTCB is able to offer highly scalable computer-based testing through the world's largest network of testing centers.

Studies show without a doubt that Americans support a standard of excellence for pharmacy technicians. A recent poll commissioned by PTCB confirms that 91% of American consumers support strong regulations across the country to protect patient safety by requiring that pharmacy technicians are trained and certified. While states like Florida reflect this growing need for action, almost twenty other states still have no requirement for certification. Clearly, consumers are relying on state boards of pharmacy to protect them and enact strong requirements such as Florida's for pharmacy technicians.

About the Pharmacy Technician Certification Board (PTCB) (http://www.ptcb.org/)

PTCB was established in January 1995 and is governed by five pharmacy organizations - the American Pharmacists Association (APhA), the American Society of Health-System Pharmacists (ASHP), the Illinois Council of Health-System Pharmacists (ICHP), the Michigan Pharmacists Association (MPA) and the National Association of Boards of Pharmacy (NABP). Since PTCB's inception, PTCB has certified over 300,000 pharmacy technicians through the examination and transfer process. PTCB's certification program is accredited by the National Commission for Certifying Agencies (NCCA). The goal of the PTCB national certification program is to enable pharmacy technicians to work more effectively with pharmacists to offer safe and effective patient care and service. PTCB contracts with Pearson VUE, the industry's technology leader, as its computer-based testing vendor. PTCB draws upon the experience and expertise of its 13-year partner, Professional Examination Service (PES) for test development.

Contact Information
Mark Franco
The Pharmacy Technician Certification Board
http://www.ptcb.org
202-429-7508
202-828-9767

Suboxone Treatment Program Launched

2008-06-27T20:51:00.000-05:00

InterventionTreatment.com Launches Suboxone Treatment Program

LOS ANGELES-- June 27, 2008 --Intervention Treatment announced today that it has launched a suboxone treatment program. The program will be used to increase Intervention Treatment's Global mission of providing Intervention and Treatment resources to those affected by alcohol and drug addiction. According to Dr. Jason Schiffman, Chief Medical Officer for Intervention Treatment, "There is a large, poorly met demand for outpatient, office-based treatment of opiate dependence and the addition of the suboxone treatment program to Intervention Treatment's array of alcohol and drug addiction related services will be a great tool for patients and their families."

Intervention Treatment is currently one of the fastest growing online resources for those affected by drug and alcohol addiction. The new Suboxone Treatment program is designed to help those affected by opiate addiction.

About Suboxone:

Suboxone is the first drug approved by the FDA for opiate dependence treatment in office based settings. This means that patients addicted to opiates may now choose to receive opiate-based treatment as an outpatient instead of in a hospital setting. Patients are evaluated and treated during office visits and receive a prescription for suboxone which they may fill at any pharmacy. Suboxone is comprised of two separate medications: buprenorphine and naloxone. Buprenorphine is a partial opiate agonist, meaning its opiate effects are significantly reduced compared to that of full opiate agonists, such as vicodin or heroin. The naloxone in suboxone is not appreciably absorbed from the digestive track when suboxone is taken orally and is in place to prevent the misuse of suboxone by injection drug users. The combination of these two medications leads to suboxone's effectiveness in treating opiate dependence.

About Suboxone Treatment:

Suboxone treatment differs significantly from standard opiate dependence treatment programs. Traditionally, opiate addicts undergoing medical detoxification have been administered either methadone or a combination of drugs, each targeting a symptom of withdrawal. The latter approach usually must take place in an inpatient setting in order to be done safely, while methadone treatment requires a patient to visit a clinic on a daily basis to receive a prescribed dose. Suboxone treatment differs from these treatments in several important ways. Firstly, a prescription for suboxone can be obtained at a specially licensed physician's office and filled at any pharmacy. This means the patient does not need to be admitted to a hospital or make daily visits to a methadone clinic in order to receive their medication. Secondly, because suboxone is a mixture of naloxone and buprenorphine, a partial opiate agonist with a long duration of action, the potential for abuse and overdose are much less than with methadone. Thirdly, because buprenorphine is a partial opiate agonist, suboxone may be easier to taper off of than full opiate agonists like methadone.

About Intervention Treatment

Intervention Treatment, formed in 2007, is an internet resource offering help to those affected by drug and alcohol addiction. Intervention Treatment provides referrals to drug and alcohol rehabs, intervention services, suboxone treatment referrals, and general information regarding addiction and treatment.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of the Company, and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contacts

Intervention Treatment
William Donovan, Co-Founder, 949-267-4113
bj@interventiontreatment.com
www.interventiontreatment.com

Physician Practice Documentation Receives CCHIT Certification

2008-06-18T15:05:00.000-05:00

Dairyland Healthcare Solutions' Physician Practice Documentation Receives 2007 CCHIT Certification

Software Complies with 100 Percent of Updated 2007 Certification Criteria

GLENWOOD, Minn.-- June 18, 2008 --The Certification Commission for Healthcare Information Technology (CCHIT®) today announced that Dairyland Healthcare Solutions' Physician Practice Documentation (PPD), Version 9.0.0 is CCHIT Certified®, and meets the Commission's ambulatory electronic health record (EHR) criteria for 2007. Ambulatory EHRs are designed for physician offices and clinics where most Americans get their healthcare. CCHIT - an independent, nonprofit organization - is the Recognized Certification Body in the United States for certifying health information technology products.

In the second year of the program's operation, the criteria and testing have been significantly enhanced. The Commission added 96 criteria to the 151 original requirements from last year. As a CCHIT Certified product has been tested and passed inspection of 100 percent of a set of updated criteria for functionality, interoperability and security.

"For 2007, the Commission raised the bar from the previous year's criteria. Ambulatory EHRs now must include electronic prescribing, demonstrate an ability to receive lab results, and show enhanced patient safety, quality, and security features," said Mark Leavitt, M.D., Ph.D., chair, CCHIT. "Investment in 2007 certified ambulatory EHRs gives providers even more powerful tools to improve quality, safety and efficiency while protecting the privacy of health information."

The CCHIT Certified mark - a "seal of approval" for EHR products - provides the first consensus-based, government-recognized benchmark for ambulatory EHR products. By looking to products with the CCHIT Certified seal, physicians and other providers can reduce their risk in selecting an EHR product, allowing them to focus their evaluation on the special needs of their practices.

"We are delighted to receive CCHIT certification," said James Burgess, CEO of Dairyland. "The CCHIT review process is rigorous and essential to ensuring that technologies carrying this important certification meet the highest safety and quality standards. We are pleased that CCHIT recognizes Dairyland's high standards," he added.

CCHIT's certification compliance criteria and its design for a certification inspection process have been thoroughly researched, taking into account the state of the art of EHRs and available standards, and comparing certification processes in other industries and other countries. The inspection process is based on real-life medical scenarios designed to test products rigorously against the clinical needs of providers and the quality and safety needs of healthcare consumers and payers. One script, for example, recreates a scenario of an elderly man with poorly controlled diabetes, hypertension and other chronic conditions in order to test EHR functions such as potential adverse drug reactions, disease management and treatment plans.

About Dairyland Healthcare Solutions

Dairyland Healthcare Solutions is an award-winning healthcare information systems company that links essential information between small community hospitals and their healthcare delivery and business networks. Dairyland enables its hospital partners to deliver the highest level of patient care by providing the information infrastructure required to operate effectively in the dynamic and complex healthcare delivery environment. For almost three decades, Dairyland has partnered with leading community hospitals to help them improve efficiencies, enhance profitability and ensure patient safety by providing solutions to manage, integrate and access key financial, clinical and patient information. Dairyland is the only company to be awarded three consecutive "Best in KLAS" ratings in the Community Hospital Information Systems category. To learn more, visit: http://www.dhsnet.com.

About CCHIT

The Certification Commission for Healthcare Information Technology (CCHIT®) is an independent, nonprofit organization that has been named by the federal government as the Recognized Certification Body for health information technology. Its mission is to accelerate the adoption of health information technology by creating a credible, sustainable certification program. The certification requirements are based on widely accepted industry standards and involve the work of hundreds of expert volunteers and input from a variety of stakeholders throughout the health care industry. More information on CCHIT and CCHIT Certified® products is available at www.cchit.org.

"CCHIT®" and "CCHIT Certified®" are service marks of the Certification Commission for Healthcare Information Technology.

Contacts

Dairyland Healthcare Solutions
Tracey Schroeder, 612-787-3125
VP Marketing & Communications
tracey.schroeder@dhsnet.com
or
CCHIT
Sue Reber, 503-703-0813
sreber@cchit.org

Victims of Asbestos Exposure Should Call the Mesothelioma Victims Center

2008-06-08T20:49:00.001-05:00

Mesothelioma Victims And All Victims of Asbestos Exposure Should Call the Mesothelioma Victims Center First For Free Honest Advise & Help

Why should victims of mesothelioma or their families call the Mesothelioma Victims Center First? According to Americas Watchdog, "its pretty simple, we will tell them the truth about treatment options, lawyers, Social Security, and everything else they need to know and our service is free". The Mesothelioma Victims Center was created to assist all US victims of Mesothelioma. Americas Watchdog has initiated this very complete free service because there is literally nothing close to this type of service in the United States, and because this type of service is sorely needed by Mesothelioma victims and their families. The Mesothelioma Victims Center was created to assist victims & their families in every way possible. Victims who served in the US Navy are especially encouraged to contact the group at 866-714-6466.

May 27, 2008 -- The Mesothelioma Victims Center is a free service designed to assist all victims of Mesothelioma, or to assist the families of victims who have this disease. What makes this service unique? According to Americas Watchdog,"our service to victims or their families is free. Mesothelioma is a rare, and lethal form of cancer related to asbestos exposure. Americas Watchdog never realized that there was no safety net for victims, to get help from the government or VA. They did not know how difficult it might be to get veterans benefits or social security benefits. Americas Watchdog also discovered that it is critical for victims of this lethal disease to get proper legal representation. They have designed the Mesothelioma Victims Center to be the national advocacy center for the victims and family members of Mesothelioma.Their service is free. The web site is located at http://MesotheliomaVictimsCenter.com.

Very Important note: According to the Mesothelioma Victims Center, "You do not want a personal injury attorney with little, to no Mesothelioma experience taking on a case, unless they have lots of experience with mesothelioma. This is especially true of US Navy veterans, who were exposed in a US naval vessel engine room. If you, or a loved one has been diagnosed with Mesothelioma, there are thousands of law firms that say they can take the case. The problem; there are only a handful of law firms in the US that can do a superior job."

According to Americas Watchdog, "Individuals who have been diagnosed with Mesothelioma, or their family members should call the Mesothelioma Victims Center first, for honest and straight forward advice at 866-714-6466". The Mesothelioma Center is all about honest, and helpful advice for all Mesothelioma victims. The Mesothelioma Victims Center web site is located at Http://MesotheliomaVictimsCenter.com.

The Mesothelioma Victims Center's services include:

* Assisting the victims of Mesothelioma in obtaining Social Security permanent disability payments

* If the victim is a veteran and was exposed to asbestos during military duty, we will work with the victim and his/her family in obtaining veterans disability and health care benefits.

* We will assist the family in getting the best possible health care options

* We will assist the victim in getting legal representation.

* We will assist the victim and their family in getting counseling on a wide variety of topics that arise from this disease.

A victim of Mesothelioma or their family can call the group any time for help, assistance and advice anytime at 866-714-6466.

Who Can Get Mesothelioma? Individuals exposed to asbestos. As Follows

* Individuals who served in the US Navy. Especially Navy personnel who served in or around naval ship engine rooms.

* Members of the US Army, Air Force, Marines, or Coast Guard.

* Naval ship yard workers

* Oil refinery workers

* Ship yard workers

* Automotive repair specialists

* Construction workers

* Plumbers

* Demolition contractors

Important note to doctors and medical staff: Please tell your patients about the Mesothelioma Victims Center.

Because no other group is providing this full range of services, and because victims and their families need assistance in these areas, Americas Watchdog is doing all of this at no charge, because its the right thing to do. Americas Watchdog's Mesothelioma Victims Center web site is located at http://MesotheliomaVictimsCenter.com. Anyone wishing more information can call the Mesothelioma Victims Center anytime at 866-714-6466. Health care workers or physicians are encouraged to tell your patients about the Mesothelioma Victims Center.

Americas Watchdog and its Mesothelioma Victims Center are all about taking care of precious souls in need, and corporate responsibility.

Contact Information
THOMAS MARTIN
Americas Watchdog
Http://MesotheliomaVictimsCenter.Com
866-714-6466